## CB: Chubb Limited - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -2.2% below STRENGTH zone (4.0-10.0%); PEG 2.26 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($286.74)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Chubb Limited (CB): A Bull Case Theory**
- Source: Finviz | 20251205T050902 | Bullish | Relevance: 100%
- This article summarizes a bullish thesis on Chubb Limited (CB), highlighting its undervaluation at 12x earnings with a 15% ROE, its elite client base, and structural advantages creating a strong moat. The company's disciplined underwriting and aggressive share buybacks further bolster its investment appeal, suggesting potential for mid-teens annual returns and substantial upside if the market re-prices safety.

**2. How Chubb’s Dividend and Cyber Risk Findings Could Shape Chubb (CB) Investors’ Long-Term View**
- Source: Simply Wall Street | 20251204T160818 | Somewhat-Bullish | Relevance: 100%
- Chubb (CB) recently declared a quarterly dividend of US$0.97 per share and a survey by the company highlighted that cyber risk is the top perceived risk among affluent North Americans, yet only 41% have standalone cyber insurance. The article explores how these factors, coupled with Chubb's focus on specialized and international insurance lines, could influence the company's investment narrative and long-term positioning. Investors are encouraged to consider the balance between shareholder returns and investment in product areas like cyber insurance, especially amidst a softer property and casualty market.

**3. Chubb Limited (CB): A Bull Case Theory**
- Source: Insider Monkey | 20251204T141500 | Bullish | Relevance: 100%
- This article summarizes a bullish thesis on Chubb Limited (CB), highlighting its undervaluation at 12x earnings with a 15% ROE. The company benefits from underwriting bespoke risks for elite clients, leading to high margins, robust investment income, and significant structural advantages. Despite potential volatility from catastrophes, Chubb's diversified risk pool, disciplined underwriting, and share buybacks position it for compounding book value and annual returns of 10-15%, with substantial upside if the market re-prices safety.

**4. Is Chubb Still Attractively Priced After Doubling Over the Last 5 Years?**
- Source: Simply Wall Street | 20251205T164013 | Bullish | Relevance: 100%
- Chubb (NYSE: CB) has seen its stock double over the last five years and is currently trading around $295 a share. Despite this, a Simply Wall St analysis suggests that the stock is still attractively priced, scoring 4 out of 6 for being undervalued across key metrics. The valuation is supported by an excess returns model indicating a 54.2% undervaluation and a P/E ratio below its proprietary Fair Ratio, suggesting potential for further appreciation.

**5. GeoWealth Management LLC Has $2.92 Million Stake in Chubb Limited $CB**
- Source: MarketBeat | 20251205T124842 | Somewhat-Bullish | Relevance: 100%
- GeoWealth Management LLC significantly reduced its stake in Chubb Limited by 32.6% in the second quarter, now holding 10,089 shares valued at $2.92 million. Despite this, Chubb has shown strong financial performance, beating earnings estimates with an EPS of $7.49 and revenue of $16.15 billion, and declared a quarterly dividend of $0.97 per share. Analysts generally rate Chubb as "Hold" with an average target price of $308.32, while corporate insiders have sold shares worth over $16.6 million recently.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Morgan Stanley | $300 | $295 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 7 ($14.78M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (-0.3%)
- Berkshire Hathaway, : 7.6% (+15.9%)
- Blackrock Inc.: 6.7% (+0.6%)
- State Street Corpora: 4.1% (+0.4%)
- FMR, LLC: 3.0% (-11.2%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-1.6% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $15M sold (7 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.26 elevated, pricing in significant growth expectations. Quality metrics strong (margin 16%). Balance sheet: strong liquidity (10.9x). Insider selling cluster ($14.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $125.0B |
| Beta | 0.52 |
| 52W Range | $252.16 - $314.68 |
| Short Interest | 0.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.26 |
| Forward P/E | 11.2 |
| Current P/E | 12.5 |
| YoY Growth | 11.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -0.6% to -2.2% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.2pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-0.70), momentum weakening. RSI neutral at 58. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: +SLH (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.23% (CS: 35) | Weak |
| RSI_14 | 58.0 | Neutral |
| MACD Histogram | -0.70 | Bearish |
| vs SMA20 | 1.001x | Above |
| vs SMA50 | 1.032x | Above |
| vs SMA200 | 1.041x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $295.00
- **Stop Loss:** $286.74 (2.8% risk)
- **Target:** $303.26 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 121
- **Position Value:** $35,695.00
- **Portfolio %:** 35.70%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-01-27 (Est: $6.49)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.16 | $7.49 | +21.7% |
| 2025Q2 | $5.97 | $6.14 | +2.8% |
| 2025Q1 | $3.23 | $3.68 | +14.0% |
| 2024Q4 | $5.45 | $6.02 | +10.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*